The revenue beat and raised guidance are positive catalysts, but the large EPS miss and increased operating spend may limit upside. Monitor the Q3 earnings call for updates on account growth trajectory and expense management; the IP litigation outcome and tariff refund sustainability are key swing factors.
Price Chart
Executive Summary
Ceribell reported Q2 2026 revenue of $28.1M (+33% YoY, beating consensus of $27.3M by 2.9%) but GAAP EPS of -$0.51 missed the -$0.46 consensus by 10.9%. The company raised full-year 2026 revenue guidance to $114-117M, reflecting strong account growth and utilization. The net loss widened to $19.3M on higher operating expenses, including IP litigation costs and stock-based compensation.
Key Financial Metrics
Key Facts
- Q2 2026 total revenue $28.1M (+33% YoY vs $21.2M); product revenue $21.2M (+33%), subscription revenue $6.9M (+30%)
- GAAP EPS -$0.51 vs consensus -$0.46 (-10.9% miss); net loss $19.3M vs $13.6M in Q2 2025
- Gross margin improved to 92% from 88%, aided by tariff refunds and manufacturing cost initiatives
- Raised FY2026 revenue guidance to $114-117M (28-31% YoY growth)
- Operating expenses $45.9M (+37% YoY) driven by commercial expansion, R&D, and IP litigation costs
- Cash and marketable securities $129.3M as of June 30; new $60M credit facility secured in August
- Received multiple FDA 510(k) clearances for detection algorithms and next-gen hardware platform
- Ended quarter with 712 active accounts
Financial Impact
Revenue beat by ~$0.8M (2.9%) and raised guidance signal strong demand, but EPS miss of 10.9% and widening net loss temper enthusiasm
Risk Factors
- IP litigation costs and outcomes could continue to pressure margins
- Operating expense growth outpacing revenue growth (37% vs 33%)
- Dependence on tariff refunds and manufacturing in Asia for gross margin
- Competitive pressure from larger medtech companies in EEG monitoring
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3342200 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | Press Release | $27.14 $27.40 | ▲ +0.96% | ▲ +2.14% | $27.22 (+0.29%) |
Sep 17, 2026 5w ago | Insider Cluster | $24.37 $24.25 | ▼ −0.49% | ▼ −2.04% | $27.22 (+11.69%) |
Sep 10, 2026 6w ago | Insider Cluster | $23.63 $24.33 | ▼ −2.96% | ▼ −3.41% | $27.22 (−15.19%) |
Sep 4, 2026 7w ago | Insider Cluster | $24.31 $24.41 | ▲ +0.41% | ▲ +0.88% | $27.22 (+11.97%) |
Aug 25, 2026 9w ago | Insider Cluster | $23.45 $23.37 | ▲ +0.34% | ▲ +1.00% | $27.22 (−16.08%) |
Aug 20, 2026 9w ago | Insider Cluster | $24.20 $23.94 | ▲ +1.07% | ▲ +0.78% | $27.22 (−12.48%) |
Aug 20, 2026 9w ago | Insider Cluster | $24.20 $23.94 | ▼ −1.07% | ▼ −0.78% | $27.22 (+12.48%) |
Aug 18, 2026 10w ago | Institutional Cluster | $24.21 $24.89 | ▲ +2.81% | ▲ +2.60% | $27.22 (+12.43%) |
Aug 10, 2026 11w ago | 8-K | $21.31 $22.91 | ▲ +7.51% | ▲ +7.26% | $27.22 (+27.73%) |
Aug 10, 2026 11w ago | Press Release | $21.31 $22.91 | ▲ +7.51% | ▲ +7.26% | $27.22 (+27.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers